Process to manufacture novel inhibited hydrofluoric acid composition

US12091601B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12091601-B2
Application numberUS-202217987004-A
CountryUS
Kind codeB2
Filing dateNov 15, 2022
Priority dateJun 12, 2020
Publication dateSep 17, 2024
Grant dateSep 17, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process for controlling the heat generated during the manufacture an inhibited hydrofluoric acid aqueous composition comprising: hydrofluoric acid in solution; a weak base; and an alkanolamine; said process comprising the steps of: providing a pre-determined amount of weak base; adding a pre-determined amount of said hydrofluoric acid to said weak base and obtaining a solution; adding said alkanolamine to the resulting solution of hydrofluoric acid and weak base; mixing until all components are dissolved; wherein said alkanolamine and hydrofluoric acid are present in a molar ratio of at least 1:1.

First claim

Opening claim text (preview).

The invention claimed is: 1. An inhibited hydrofluoric acid aqueous composition comprising: hydrofluoric acid in solution; a weak base; and an alkanolamine; wherein the molar ratio of weak base and alkanolamine to hydrofluoric acid in the composition is at least 1:1, and wherein the composition is produced by a process comprising: combining a pre-determined amount of hydrofluoric acid with a predetermined amount of the weak base to obtain a first solution; adding a predetermined amount of the alkanolamine to the first solution to obtain a second solution; and mixing the second solution to form the inhibited hydrofluoric acid aqueous composition; wherein the process is performed such that the inhibited hydrofluoric acid aqueous composition has an HF:alkanolamine:weak base ratio ranging from 1:1:0.02 to 1:1:0.5. 2. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the molar ratio of weak base and alkanolamine to hydrofluoric acid in the composition is at least 1.05:1. 3. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the molar ratio of weak base and alkanolamine to hydrofluoric acid in the composition is at least 1.1:1. 4. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the alkanolamine is selected from the group consisting of monoethanolamine, diethanolamine, triethanolamine, and any combination thereof. 5. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the alkanolamine is monoethanolamine. 6. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the alkanolamine is diethanolamine. 7. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the alkanolamine is triethanolamine. 8. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the weak base is selected from the group consisting of lysine, triazole, imidazole, hydantoin, and n-methylimidazole. 9. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the weak base is imidazole. 10. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the weak base is present in an amount ranging from 0.05 to 0.2 moles for each mole of HF present. 11. The inhibited hydrofluoric acid aqueous composition of claim 1 , wherein the process is performed such that the inhibited hydrofluoric acid aqueous composition has an HF:alkanolamine:weak base ratio ranging from 1:1:0.05 to 1:1:0.1. 12. A glass etching composition comprising: an inhibited hydrofluoric acid aqueous composition according to claim 1 ; and a mineral acid. 13. The glass etching composition of claim 12 , wherein the mineral acid is HCl. 14. The glass etching composition of claim 12 , wherein the alkanolamine is selected from the group consisting of monoethanolamine, diethanolamine, triethanolamine, and any combination thereof; and the weak base is selected from the group consisting of lysine, triazole, imidazole, hydantoin, and n-methylimidazole. 15. An inhibited hydrofluoric acid aqueous composition comprising: hydrofluoric acid in solution; a weak base; and an alkanolamine; wherein the molar ratio of weak base and alkanolamine to hydrofluoric acid in the composition is at least 1:1, and wherein the composition is produced by a process comprising: preparing a first solution comprising a weak base; combining a pre-determined amount of hydrofluoric acid with the first solution to obtain a second solution; adding a predetermined amount of the alkanolamine to the second solution to obtain a third solution; and mixing the third solution to form the inhibited hydrofluoric acid aqueous composition, wherein the process is performed such that the inhibited hydrofluoric acid aqueous composition has an HF:alkanolamine:weak base ratio ranging from 1:1:0.02 to 1:1:0.5. 16. The inhibited hydrofluoric acid aqueous composition of claim 15 , wherein the process is performed such that the inhibited hydrofluoric acid aqueous composition has an HF:alkanolamine:weak base ratio ranging from 1:1:0.05 to 1:1:0.1. 17. the inhibited hydrofluoric acid aqueous composition of claim 15 , wherein the alkanolamine is selected from the group consisting of monoethanolamine, diethanolamine, triethanolamine, and any combination thereof. 18. The inhibited hydrofluoric acid aqueous composition of claim 15 , wherein the weak base is selected form the group consisting of lysine, triazole, imidazole, hydantoin, and n-methylimidazole. 19. A glass etching composition comprising: an inhibited hydrofluoric acid aqueous composition according to claim 15 , and a mineral acid. 20. The glass etching composition of claim 19 , wherein the mineral acid is HCl; the alkanolamine is selected form the group consisting of monoethanolamine, diethanolamine, triethanolamine, and any combination thereof; and the weak base is selected from the group consisting of lysine, triazole, imidazole, hydantoin, and n-methylimidazole.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12091601B2 cover?
A process for controlling the heat generated during the manufacture an inhibited hydrofluoric acid aqueous composition comprising: hydrofluoric acid in solution; a weak base; and an alkanolamine; said process comprising the steps of: providing a pre-determined amount of weak base; adding a pre-determined amount of said hydrofluoric acid to said weak base and obtaining a solu…
Who is the assignee on this patent?
Fluid Energy Group Ltd, Dorf Ketal Chemicals Fze
What technology area does this patent fall under?
Primary CPC classification C09K13/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).